The Pharmaceutical Market: Switzerland

Date: January 31, 2013
Pages: 85
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PE68B8EA1F6EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Switzerland
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SWITZERLAND

While the patent cliff and the consequent availability of generic drugs, as well as price cuts on generic medicines and their increasing affordability, will work towards increasing the consumption of generic medicines in Switzerland, BMI believes the government needs to do more to alter patients' attitudes towards these drugs as this the main deterrent of growth.

Headline Expenditure Projections

Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% decline in local currency terms and -8.2% in US dollar terms.

Healthcare: CHF65.30bn (US$73.6bn) in 2011 to CHF67.42bn (US$71.72bn) in 2012; +3.2% growth in local currency terms and -2.6% in US dollar terms.

Medical devices: CHF4.77bn (US$5.38bn) in 2011 to CHF4.76bn (US$5.06bn) in 2012; -0.3% growth in local currency term s and -5.8% in US dollar terms.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI INDUSTRY VIEW

EXECUTIVE SUMMARY

SWOT

SWITZERLAND PHARMACEUTICALS AND HEALTHCARE INDUSTRY SWOT

INDUSTRY FORECAST

OVERALL MARKET FORECAST

KEY GROWTH FACTORS - INDUSTRY

   Table: Table: Healthcare Expenditure Indicators 2009-2016
   Table: Table: Healthcare Governmental Indicators 2009-2016
   Table: Table: Healthcare Private Indicators 2009-2016

ECONOMIC ANALYSIS

   Table: Macro Indicators

PRESCRIPTION DRUG MARKET FORECAST

   Table: Table: Prescription Drug Sales Indicators 2009-2016

PATENTED DRUG MARKET FORECAST

   Table: Table: Patented Drug Market Indicators 2009-2016

GENERIC DRUG MARKET FORECAST

   Table: Table: Generic Drug Sales Indicators 2009-2016

OTC MEDICINE MARKET FORECAST

   Table: Table: OTC Medicine Sales Indicators 2009-2016

PHARMACEUTICAL TRADE FORECAST

   Table: Table: Exports and Imports Indicators 2009-2016

MEDICAL DEVICE MARKET FORECAST

   Table: Table: Medical Devices Sales Indicators 2009-2016

OTHER HEALTHCARE DATA FORECASTS

INDUSTRY RISK REWARD RATINGS

PHARMACEUTICAL RISK/REWARD RATINGS

   Table: Western Europe Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113

MARKET OVERVIEW

MARKET OVERVIEW

INDUSTRY TRENDS AND DEVELOPMENTS

INDUSTRY TRENDS AND DEVELOPMENTS

   Table: 2013: Health Insurance Premiums

REGULATORY DEVELOPMENT

REGULATORY REGIME

COMPETITIVE LANDSCAPE

© BUSINESS MONITOR INTERNATIONALPAGE

Switzerland Pharmaceuticals & Healthcare Report Q1 2013

COMPETITIVE LANDSCAPE

COMPANY PROFILE

NOVARTIS

ROCHE

MERCK SERONO

GLAXOSMITHKLINE

PFIZER

SANOFI

MERCK & CO.

METHODOLOGY

METHODOLOGY

  Risk/Reward Ratings Methodology
  Ratings Overview
   Table: Pharmaceutical Business Environment Indicators
  Weighting
   Table: Weighting Of Components
  Sources

GLOSSARY
Skip to top


Ask Your Question

The Pharmaceutical Market: Switzerland
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: